Point72 Asset Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Buy |
+498,219
| New | +$3.43M | 0.01% | 761 |
|
|
2024
Q2 | – | Sell |
-223,400
| Closed | -$2.11M | – | 1394 |
|
|
2024
Q1 | $2.11M | Buy |
+223,400
| New | +$2.11M | 0.01% | 857 |
|
|
2023
Q3 | – | Sell |
-1,899,968
| Closed | -$6.27M | – | 1903 |
|
|
2023
Q2 | $6.27M | Sell |
1,899,968
-743,704
| -28% | -$2.45M | 0.02% | 625 |
|
|
2023
Q1 | $7.53M | Buy |
+2,643,672
| New | +$7.53M | 0.02% | 563 |
|
|
2022
Q4 | – | Sell |
-1,494,003
| Closed | -$12.1M | – | 1207 |
|
|
2022
Q3 | $12.1M | Sell |
1,494,003
-494,797
| -25% | -$4M | 0.05% | 426 |
|
|
2022
Q2 | $9.75M | Buy |
1,988,800
+1,663,800
| +512% | +$8.15M | 0.04% | 458 |
|
|
2022
Q1 | $7.69M | Sell |
325,000
-180,655
| -36% | -$4.27M | 0.03% | 533 |
|
|
2021
Q4 | $8.95M | Buy |
505,655
+365,655
| +261% | +$6.47M | 0.04% | 514 |
|
|
2021
Q3 | $3.95M | Sell |
140,000
-412,885
| -75% | -$11.6M | 0.02% | 655 |
|
|
2021
Q2 | $5.79M | Sell |
552,885
-22,361
| -4% | -$234K | 0.03% | 544 |
|
|
2021
Q1 | $6.78M | Sell |
575,246
-762,877
| -57% | -$8.99M | 0.03% | 492 |
|
|
2020
Q4 | $15.7M | Sell |
1,338,123
-171,877
| -11% | -$2.01M | 0.08% | 320 |
|
|
2020
Q3 | $12M | Buy |
1,510,000
+1,249,303
| +479% | +$9.91M | 0.06% | 355 |
|
|
2020
Q2 | $4.77M | Buy |
+260,697
| New | +$4.77M | 0.03% | 463 |
|